Table 3. Baseline clinical characteristics of the LVH and non-LVH groups.
| Characteristics (n=1,045) | LVH group (n=270) | Non-LVH group (n=775) | P value |
|---|---|---|---|
| Age (year) | 63.36±9.51 | 62.65±9.38 | NS |
| Male, n (%) | 189 (70.0) | 482 (62.2) | <0.05 |
| HBP history, n (%) | 199 (73.7) | 435 (56.1) | <0.01 |
| OMI history, n (%) | 25 (9.3) | 51 (6.6) | NS |
| CHF history, n (%) | 122 (45.2) | 93 (12.0) | <0.01 |
| DM history, n (%) | 65 (24.1) | 128 (16.5) | <0.01 |
| BMI (kg/m2) | 20.86±1.50 | 20.95±1.56 | NS |
| Heart rate (rpm) | 71.25±13.07 | 72.62±14.48 | NS |
| SBP (mmHg) | 134.95±21.88 | 132.19±18.61 | NS |
| DBP (mmHg) | 80.47±12.85 | 78.90±10.77 | NS |
| SCr (μmol/L) | 87.53 ±31.67 | 76.19±21.14 | <0.01 |
| eCCr (mL/min/1.73 m2) | 80.11±20.62 | 87.36±16.83 | <0.01 |
| HbA1C (%) | 6.25±0.97 | 6.30±6.63 | NS |
| cTnT (ng/mL) | 0.034±0.098 | 0.011±0.021 | <0.01 |
| NT-proBNP (ng/L) | 1609.13±3331.68 | 303.56±634.29 | <0.01 |
| LVEF (%) | 54.43±13.70 | 64.45±6.33 | <0.01 |
| LADi (cm/m2) | 2.88±0.44 | 2.46±0.33 | <0.01 |
| LVMi (g/m2) | 154.56±36.59 | 91.92±16.63 | <0.01 |
LVH, left ventricular hypertrophy; HBP, hypertension; OMI, old myocardial infarction; CHF, congestive heart failure; DM, diabetes mellitus; BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; SCr, serum creatinine; eCCr, endogenous creatinine clearance rate; HbA1C, Glycosylated hemoglobin; NT-proBNP, N terminal pro B type natriuretic peptide; cTnT, Cardiac troponin T; LVEF, left ventricular ejection fraction; LADi, left atrial diameter index; LVMi, left ventricular mass index.